Most Recent

image: Among the Amish, c. 1960s

Among the Amish, c. 1960s

By Diana Kwon | May 1, 2018

Victor McKusick’s pioneering investigations provided insight into hereditary disorders.

0 Comments

Research suggests that the invasive, all-female Procambarus virginalis originated in a German aquarium back in the 1990s.

0 Comments

image: Rare Disease Geneticist: A Profile of Uta Francke

Rare Disease Geneticist: A Profile of Uta Francke

By Anna Azvolinsky | May 1, 2018

The Stanford University human geneticist identified the genes and genomic abnormalities underlying numerous rare diseases, including Rett  syndrome, and advanced the field of molecular diagnostics. 

0 Comments

The UCLA geneticist examines how defects in a histone protein lead to symptoms throughout the body.

0 Comments

When the O’Neills learned that their daughter had Sanfilippo syndrome, a devastating rare disease, they created a GoFundMe campaign that raised $2 million in less than a year.

0 Comments

image: Exome Sequencing Helps Crack Rare Disease Diagnosis

Exome Sequencing Helps Crack Rare Disease Diagnosis

By Amanda B. Keener | May 1, 2018

Clinical analyses of patients’ gene sequences are helping to provide answers where none were available before.

0 Comments

Crowdfunding can power investigations into diseases that would otherwise receive little attention.

0 Comments

image: Slow March Toward a Canavan Cure

Slow March Toward a Canavan Cure

By Ashley Yeager | May 1, 2018

Two decades after a successful crowdfunding campaign, some clinical trial patients have seen improvements—but there’s still no approved treatment for the disease.

0 Comments

DNA from a relative of the suspect submitted to the site GEDmatch gave investigators just enough information to identify him, but the process raises privacy concerns.

1 Comment

Researchers used the genome sequence of Artemisia annua to boost the plant’s production of artemisinin.

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. “Public” T-Cell Receptors From Resistant People Fend Off HIV